/PRNewswire/ On September 26, 2023, Kimera® Labs Inc., a privately held clinical stage biotechnology company, responded to a Warning Letter (WL) received.
/PRNewswire/ Kimera® Labs Inc., the first and leading worldwide MSC exosome research lab and producer, is pleased to announce the FDA IND (Investigational.
MIRAMAR, Fla., May 16, 2023 /PRNewswire/ Kimera® Labs Inc., the first and leading worldwide MSC exosome research lab and producer, is pleased to announce the FDA IND (Investigational New